Defence is the Best Attack: Immuno-Oncology Breakthroughs

In this conference, we will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies including the identification of novel targets; an improved understanding of the mechanisms of action of therapeutic interventions; as well as discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy. Richard Flavell (Yale University School of Medicine), Laurence Zitvogel (Gustave Roussy) and George Coukos (Ludwig Institute for Cancer Research) will give keynote lectures.

Who should attend? The target audience for this conference is basic and translational scientists and clinicians, both senior and young investigators that want to have a broad and detailed overview of the most recent advances in the field of immunotherapy.